Thursday, May 18, 2017

Oncogene - Table of Contents alert Volume 36 Issue 20

If you are unable to see the message below, click here to view.


New: Diagenode Epigenomic Profiling Services

  • Complete chromatin modification and DNA methylation analysis with bioinformatics
  • Choice in level of service: complete or partial
  • Expertise in low input samples
  • Fast results typically in 8-10 weeks at a low cost

Learn more about our Epigenomic Profiling Services


Volume 36, Issue 20 (May 2017)

In this issue
Original Articles
Short Communication

Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed

Original Articles


Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms

J Feng, L Li, N Zhang, J Liu, L Zhang, H Gao, G Wang, Y Li, Y Zhang, X Li, D Liu, J Lu and B Huang

Oncogene 2017 36: 2775-2790; advance online publication, November 28, 2016; 10.1038/onc.2016.432

Abstract | Full Text

MUC1-C activates BMI1 in human cancer cells

M Hiraki, T Maeda, A Bouillez, M Alam, A Tagde, K Hinohara, Y Suzuki, T Markert, M Miyo, K Komura, R Ahmad, H Rajabi and D Kufe

Oncogene 2017 36: 2791-2801; advance online publication, November 28, 2016; 10.1038/onc.2016.439

Abstract | Full Text

DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer OPEN

Y M Choi, K B Kim, J H Lee, Y K Chun, I S An, S An and S Bae

Oncogene 2017 36: 2802-2812; advance online publication, December 12, 2016; 10.1038/onc.2016.441

Abstract | Full Text

TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression

C Jiang, Y Zhu, Z Zhou, J Gumin, L Bengtsson, W Wu, Z Songyang, F F Lang and X Lin

Oncogene 2017 36: 2813-2823; advance online publication, December 19, 2016; 10.1038/onc.2016.430

Abstract | Full Text

The induction of MIG6 under hypoxic conditions is critical for dormancy in primary cultured lung cancer cells with activating EGFR mutations

H Endo, J Okami, H Okuyama, Y Nishizawa, F Imamura and M Inoue

Oncogene 2017 36: 2824-2834; advance online publication, November 28, 2016; 10.1038/onc.2016.431

Abstract | Full Text

Phosphorylation of NFAT3 by CDK3 induces cell transformation and promotes tumor growth in skin cancer OPEN

T Xiao, J J Zhu, S Huang, C Peng, S He, J Du, R Hong, X Chen, A M Bode, W Jiang, Z Dong and D Zheng

Oncogene 2017 36: 2835-2845; advance online publication, November 28, 2016; 10.1038/onc.2016.434

Abstract | Full Text

Cooperation among heterogeneous prostate cancer cells in the bone metastatic niche

K Shahriari, F Shen, A Worrede-Mahdi, Q Liu, Y Gong, F U Garcia and A Fatatis

Oncogene 2017 36: 2846-2856; advance online publication, December 19, 2016; 10.1038/onc.2016.436

Abstract | Full Text

Evolution and heterogeneity of non-hereditary colorectal cancer revealed by single-cell exome sequencing

H Wu, X-Y Zhang, Z Hu, Q Hou, H Zhang, Y Li, S Li, J Yue, Z Jiang, S M Weissman, X Pan, B-G Ju and S Wu

Oncogene 2017 36: 2857-2867; advance online publication, December 12, 2016; 10.1038/onc.2016.438

Abstract | Full Text

Inhibition of KPNA4 attenuates prostate cancer metastasis

J Yang, C Lu, J Wei, Y Guo, W Liu, L Luo, G Fisch and X Li

Oncogene 2017 36: 2868-2878; advance online publication, December 12, 2016; 10.1038/onc.2016.440

Abstract | Full Text

Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3KAKTGSK3βAM signaling OPEN

Y Chen, C Li, H Xie, Y Fan, Z Yang, J Ma, D He and L Li

Oncogene 2017 36: 2879-2888; advance online publication, January 23, 2017; 10.1038/onc.2016.442

Abstract | Full Text

Intracellular IL-37b interacts with Smad3 to suppress multiple signaling pathways and the metastatic phenotype of tumor cells

C Luo, Y Shu, J Luo, D Liu, D-S Huang, Y Han, C Chen, Y-C Li, J-M Zou, J Qin, Y Wang, D Li, S-S Wang, G-M Zhang, J Chen and Z-H Feng

Oncogene 2017 36: 2889-2899; advance online publication, January 16, 2017; 10.1038/onc.2016.444

Abstract | Full Text

Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity

D Zhang, N Jin, W Sun, X Li, B Liu, Z Xie, J Qu, J Xu, X Yang, Y Su, S Tang, H Han, D Chen, J Ding, M Tan, M Huang and M Geng

Oncogene 2017 36: 2900-2909; advance online publication, December 19, 2016; 10.1038/onc.2016.446

Abstract | Full Text

Short Communication


Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer OPEN

L Yu, Y Liang, X Cao, X Wang, H Gao, S-Y Lin, R Schiff, X-S Wang and K Li

Oncogene 2017 36: 2910-2918; advance online publication, November 28, 2016; 10.1038/onc.2016.433

Abstract | Full Text



Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer

B A Patrick, X Gong and A K Jaiswal

Oncogene 2017 36: 2919; advance online publication, March 6, 2017; 10.1038/onc.2016.475

Full Text

Stress-induced NQO1 controls stability of C/EBPα against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer

B A Patrick and A K Jaiswal

Oncogene 2017 36: 2920; advance online publication, March 6, 2017; 10.1038/onc.2016.476

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: